Copyright Reports & Markets. All rights reserved.

Europe Gastrointestinal Therapeutics Market Report 2018

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Definition and Specification
    • 1.2 Report Overview
      • 1.2.1 Manufacturers Overview
      • 1.2.2 Regions Overview
      • 1.2.3 Type Overview
      • 1.2.4 Application Overview
    • 1.3 Industrial Chain
      • 1.3.1 Gastrointestinal Therapeutics Overall Industrial Chain
      • 1.3.2 Upstream
      • 1.3.3 Downstream
    • 1.4 Industry Situation
      • 1.4.1 Industrial Policy
      • 1.4.2 Product Preference
      • 1.4.3 Economic/Political Environment
    • 1.5 SWOT Analysis

    2 Market Analysis by Types

    • 2.1 Overall Market Performance(Volume)
      • 2.1.1 Type I Market Performance (Volume)
      • 2.1.2 Type II Market Performance (Volume)
    • 2.2 Overall Market Performance(Value)
      • 2.1.1 Type I Market Performance (Value)
      • 2.1.2 Type II Market Performance (Value)

    3 Product Application Market

    • 3.1 Overall Market Performance (Volume)
      • 3.1.1 IBD Market Performance (Volume)
      • 3.1.2 Irritable Bowel Syndrome (IBS) Market Performance (Volume)

    4 Manufacturers Profiles/Analysis

    • 4.1 AbbVie
      • 4.1.1 AbbVie Profiles
      • 4.1.2 AbbVie Product Information
      • 4.1.3 AbbVie Gastrointestinal Therapeutics Business Performance
      • 4.1.4 AbbVie Gastrointestinal Therapeutics Business Development and Market Status
    • 4.2 Allergan
      • 4.2.1 Allergan Profiles
      • 4.2.2 Allergan Product Information
      • 4.2.3 Allergan Gastrointestinal Therapeutics Business Performance
      • 4.2.4 Allergan Gastrointestinal Therapeutics Business Development and Market Status
    • 4.3 Johnson & Johnson
      • 4.3.1 Johnson & Johnson Profiles
      • 4.3.2 Johnson & Johnson Product Information
      • 4.3.3 Johnson & Johnson Gastrointestinal Therapeutics Business Performance
      • 4.3.4 Johnson & Johnson Gastrointestinal Therapeutics Business Development and Market Status
    • 4.4 Takeda
      • 4.4.1 Takeda Profiles
      • 4.4.2 Takeda Product Information
      • 4.4.3 Takeda Gastrointestinal Therapeutics Business Performance
      • 4.4.4 Takeda Gastrointestinal Therapeutics Business Development and Market Status
    • 4.5 Novartis
      • 4.5.1 Novartis Profiles
      • 4.5.2 Novartis Product Information
      • 4.5.3 Novartis Gastrointestinal Therapeutics Business Performance
      • 4.5.4 Novartis Gastrointestinal Therapeutics Business Development and Market Status
    • 4.6 Pfizer
      • 4.6.1 Pfizer Profiles
      • 4.6.2 Pfizer Product Information
      • 4.6.3 Pfizer Gastrointestinal Therapeutics Business Performance
      • 4.6.4 Pfizer Gastrointestinal Therapeutics Business Development and Market Status
    • 4.7 Merck
      • 4.7.1 Merck Profiles
      • 4.7.2 Merck Product Information
      • 4.7.3 Merck Gastrointestinal Therapeutics Business Performance
      • 4.7.4 Merck Gastrointestinal Therapeutics Business Development and Market Status
    • 4.8 F. Hoffmann-La Roche
      • 4.8.1 F. Hoffmann-La Roche Profiles
      • 4.8.2 F. Hoffmann-La Roche Product Information
      • 4.8.3 F. Hoffmann-La Roche Gastrointestinal Therapeutics Business Performance
      • 4.8.4 F. Hoffmann-La Roche Gastrointestinal Therapeutics Business Development and Market Status
    • 4.9 Eli Lilly
      • 4.9.1 Eli Lilly Profiles
      • 4.9.2 Eli Lilly Product Information
      • 4.9.3 Eli Lilly Gastrointestinal Therapeutics Business Performance
      • 4.9.4 Eli Lilly Gastrointestinal Therapeutics Business Development and Market Status
    • 4.10 AstraZeneca
      • 4.10.1 AstraZeneca Profiles
      • 4.10.2 AstraZeneca Product Information
      • 4.10.3 AstraZeneca Gastrointestinal Therapeutics Business Performance
      • 4.10.4 AstraZeneca Gastrointestinal Therapeutics Business Development and Market Status
    • 4.11 Procter & Gamble
    • 4.12 Tillotts Pharma
    • 4.13 Johnson & Johnson
    • 4.14 Takeda
    • 4.15 Novartis

    5 Market Performance for Manufacturers

    • 5.1 Europe Gastrointestinal Therapeutics Sales (K Units) and Market Share by Manufacturers 2013-2018
    • 5.2 Europe Gastrointestinal Therapeutics Revenue (M USD) and Market Share by Manufacturers 2013-2018
    • 5.3 Europe Gastrointestinal Therapeutics Price (USD/Unit) of Manufacturers 2013-2018
    • 5.4 Europe Gastrointestinal Therapeutics Gross Margin of Manufacturers 2013-2018
    • 5.5 Market Concentration

    6 Regions Market Performance for Manufacturers

    • 6.1 Germany Market Performance for Manufacturers
      • 6.1.1 Germany Gastrointestinal Therapeutics Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.1.2 Germany Gastrointestinal Therapeutics Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.1.3 Germany Gastrointestinal Therapeutics Price (USD/Unit) of Manufacturers 2013-2018
      • 6.1.4 Germany Gastrointestinal Therapeutics Gross Margin of Manufacturers 2013-2018
      • 6.1.5 Market Concentration
    • 6.2 UK Market Performance for Manufacturers
      • 6.2.1 UK Gastrointestinal Therapeutics Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.2.2 UK Gastrointestinal Therapeutics Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.2.3 UK Gastrointestinal Therapeutics Price (USD/Unit) of Manufacturers 2013-2018
      • 6.2.4 UK Gastrointestinal Therapeutics Gross Margin of Manufacturers 2013-2018
      • 6.2.5 Market Concentration
    • 6.3 France Market Performance for Manufacturers
      • 6.3.1 France Gastrointestinal Therapeutics Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.3.2 France Gastrointestinal Therapeutics Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.3.3 France Gastrointestinal Therapeutics Price (USD/Unit) of Manufacturers 2013-2018
      • 6.3.4 France Gastrointestinal Therapeutics Gross Margin of Manufacturers 2013-2018
      • 6.3.5 Market Concentration
    • 6.4 Russia Market Performance for Manufacturers
      • 6.4.1 Russia Gastrointestinal Therapeutics Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.4.2 Russia Gastrointestinal Therapeutics Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.4.3 Russia Gastrointestinal Therapeutics Price (USD/Unit) of Manufacturers 2013-2018
      • 6.4.4 Russia Gastrointestinal Therapeutics Gross Margin of Manufacturers 2013-2018
      • 6.4.5 Market Concentration
    • 6.5 Benelux Market Performance for Manufacturers
      • 6.5.1 Benelux Gastrointestinal Therapeutics Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.5.2 Benelux Gastrointestinal Therapeutics Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.5.3 Benelux Gastrointestinal Therapeutics Price (USD/Unit) of Manufacturers 2013-2018
      • 6.5.4 Benelux Gastrointestinal Therapeutics Gross Margin of Manufacturers 2013-2018
      • 6.5.5 Market Concentration
    • 6.6 Italy Market Performance for Manufacturers
      • 6.6.1 Italy Gastrointestinal Therapeutics Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.6.2 Italy Gastrointestinal Therapeutics Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.6.3 Italy Gastrointestinal Therapeutics Price (USD/Unit) of Manufacturers 2013-2018
      • 6.6.4 Italy Gastrointestinal Therapeutics Gross Margin of Manufacturers 2013-2018
      • 6.6.5 Market Concentration
    • 6.7 Spain Market Performance for Manufacturers
      • 6.7.1 Spain Gastrointestinal Therapeutics Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.7.2 Spain Gastrointestinal Therapeutics Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.7.3 Spain Gastrointestinal Therapeutics Price (USD/Unit) of Manufacturers 2013-2018
      • 6.7.4 Spain Gastrointestinal Therapeutics Gross Margin of Manufacturers 2013-2018
      • 6.7.5 Market Concentration
    • 6.8 Market Performance for Manufacturers
      • 6.8.1 Gastrointestinal Therapeutics Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.8.2 Gastrointestinal Therapeutics Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.8.3 Gastrointestinal Therapeutics Price (USD/Unit) of Manufacturers 2013-2018
      • 6.8.4 Gastrointestinal Therapeutics Gross Margin of Manufacturers 2013-2018
      • 6.8.5 Market Concentration

    7 Europe Gastrointestinal Therapeutics Market Performance (Sales Point)

    • 7.1 Europe Gastrointestinal Therapeutics Sales (K Units) and Market Share by Regions 2013-2018
    • 7.2 Europe Gastrointestinal Therapeutics Revenue (M USD) and Market Share by Regions 2013-2018
    • 7.3 Europe Gastrointestinal Therapeutics Price (USD/Unit) by Regions 2013-2018
    • 7.4 Europe Gastrointestinal Therapeutics Gross Margin by Regions 2013-2018

    8 Development Trend for Regions (Sales Point)

    • 8.1 Europe Gastrointestinal Therapeutics Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.2 Germany Gastrointestinal Therapeutics Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.3 UK Gastrointestinal Therapeutics Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.4 France Gastrointestinal Therapeutics Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.5 Russia Gastrointestinal Therapeutics Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.6 Benelux Gastrointestinal Therapeutics Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.7 Italy Gastrointestinal Therapeutics Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.8 Spain Gastrointestinal Therapeutics Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.8 Spain Gastrointestinal Therapeutics Sales and Growth, Sales Value and Growth Rate2013-2018

    9 Upstream Source, Technology and Cost

    • 9.1 Upstream Source
    • 9.2 Technology
    • 9.3 Cost

    10 Channel Analysis

    • 10.1 Market Channel
    • 10.2 Distributors

    11 Consumer Analysis

    • 11.1 IBD Industry
    • 11.2 Irritable Bowel Syndrome (IBS) Industry

    12 Market Forecast 2019-2024

    • 12.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2019-2024
      • 12.1.1 Europe Gastrointestinal Therapeutics Sales (K Units), Revenue (M USD) and Market Share by Regions 2019-2024
      • 12.1.2 Europe Gastrointestinal Therapeutics Sales (K Units) and Growth Rate 2019-2024
      • 12.1.3 Germany Gastrointestinal Therapeutics Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.4 UK Gastrointestinal Therapeutics Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.5 France Gastrointestinal Therapeutics Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.6 Russia Gastrointestinal Therapeutics Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.7 Benelux Gastrointestinal Therapeutics Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.8 Italy Gastrointestinal Therapeutics Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.9 Spain Gastrointestinal Therapeutics Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
    • 12.3 Sales (K Units), Revenue (M USD) by Types 2019-2024
      • 12.3.1 Overall Market Performance
      • 12.3.2 Type I Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.3.3 Type II Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
    • 12.4 Sales by Application 2019-2024
      • 12.4.1 Overall Market Performance
      • 12.4.2 IBD Sales and and Growth Rate 2019-2024
      • 12.4.3 Irritable Bowel Syndrome (IBS) Sales and and Growth Rate 2019-2024
    • 12.5 Price (USD/Unit) and Gross Profit
      • 12.5.1 Europe Gastrointestinal Therapeutics Price (USD/Unit) Trend 2019-2024
      • 12.5.2 Europe Gastrointestinal Therapeutics Gross Profit Trend 2019-2024

    13 Conclusion

    Geographically, this report split Europe into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Gastrointestinal Therapeutics for these regions, from 2012 to 2023 (forecast), including
    Germany
    UK
    France
    Russia
    Benelux
    Italy
    Spain

    Europe Gastrointestinal Therapeutics market competition by top manufacturers/players, with Gastrointestinal Therapeutics sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    AbbVie
    Allergan
    Johnson & Johnson
    Takeda
    Novartis
    Pfizer
    Merck
    F. Hoffmann-La Roche
    Eli Lilly
    AstraZeneca
    Procter & Gamble
    Tillotts Pharma
    Shire Pharmaceuticals
    GlaxoSmithKline
    RedHill Biopharma

    On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
    Type I
    Type II

    On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Gastrointestinal Therapeutics for each application, including
    IBD
    Irritable Bowel Syndrome (IBS)

    If you have any special requirements, please let us know and we will offer you the report as you want.

    Buy now